Morepen Laboratories announced successful USFDA inspection of its Masulkhana, HP API facility with zero observations (NIL Form 483).
This marks the fourth consecutive NIL 483 inspection for the company over the past eight years.
The clearance reinforces Morepen's quality systems and enhances credibility for global supply contracts and CDMO expansion.